It was a big year for children’s health: We celebrated the U.S. Food and Drug Administration’s approval of the world’s first chimeric antigen receptor (CAR)-T cell therapy this September, followed closely by approval of the very first gene therapy to treat inherited blindness this month — both of which have their roots at Children’s Hospital of Philadelphia and the University of Pennsylvania. But besides the big headline-making breakthroughs (brilliant as they are), we wanted to know what other stories captivated our readers in 2017.
Tag Archive: Matthew Weitzman
Our research trainees at Children’s Hospital of Philadelphia go on to treat, teach, and investigate at some of the best medical institutions in the world. As the next generation of pediatric scientists, the mentors they meet while at CHOP don’t just influence their careers, but the future of children’s health, too.
Adenovirus, a common human virus that usually affects the lungs and causes respiratory tract infections, is an old friend to virologists. They have long studied how this virus interacts with host cells to understand cellular processes and reveal key regulators of cellular functions.